New approach to treatment for the 50% of people with acute eosinophilic exacerbations of asthma attacks.

Medical Mythbusting Commentary for December 4, 2024

Source:
First new treatment for asthma attacks in 50 years

Reference:

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial